Network origin in Carsten Rudolph first degree
Entity | Entity type | Industry | |
---|---|---|---|
ETHRIS GmbH
ETHRIS GmbH Miscellaneous Commercial ServicesCommercial Services ETHRIS GmbH is a German company that specializes in developing innovative therapies and vaccines using its proprietary messenger RNA technology platform. The company is based in Planegg, Germany. The company is a leader in delivering stabilized mRNA directly to the respiratory system via optimized formulation and nebulization technologies. ETHRIS is rapidly advancing its pipeline of immuno-modulation, protein replacement therapies, and differentiated vaccines, with the ultimate goal of improving patients' lives. The company was founded by Carsten Rudolph and Christian Plank, and Carsten Rudolph has been the CEO since incorporation.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Carsten Rudolph via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Hope for Vision | Director/Board Member | ||
Chameleon Biosciences, Inc.
Chameleon Biosciences, Inc. BiotechnologyHealth Technology Chameleon Biosciences, Inc. engages in the provision of a pre-clinical stage gene therapy. The company was founded by Genine Winslow and Jeffery Scott Vick and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member | |
Polymerase Capital | Investment Managers | Founder | |
Genascence Corp.
Genascence Corp. BiotechnologyHealth Technology Genascence Corp. develops gene therapy products for musculoskeletal diseases. The company was founded by Dr. Annahita Keravala and Dr. Thomas W. Chalberg in 2017 and is headquartered in Palo Alto, CA. | Biotechnology | Chief Executive Officer | |
SightGlass Vision, Inc.
SightGlass Vision, Inc. Medical SpecialtiesHealth Technology SightGlass Vision, Inc. is an American clinical-stage life sciences company that focuses on ending nearsightedness in children. The private company is based in California and is developing innovative spectacle lenses based on groundbreaking research from the University of Washington. The company's unique diffusion optics technology is aimed at reducing the progression of myopia in children. SightGlass Vision was founded in 2016 by professors Jay and Maureen Neitz, Dr. James Kuchenbecker, and Dr. Thomas Chalberg, who is the CEO of the company. | Medical Specialties | Chief Executive Officer | |
Verana Health, Inc.
Verana Health, Inc. Packaged SoftwareTechnology Services Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Haas School of Business | College/University | Masters Business Admin | |
Stanford University School of Medicine | College/University | Doctorate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Founder | |
HS LifeSciences GmbH | Investment Managers | Founder | |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Miscellaneous Commercial Services | Founder | |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy. | Medical Specialties | Founder | |
Technische Universität Darmstadt | College/University | Doctorate Degree | |
Medovent GmbH
Medovent GmbH Medical SpecialtiesHealth Technology Medovent GmbH engages in the development and manufacture of medical devices made of the biopolymer chitosan. Its main products are a nerve guide used for peripheral nerve injuries and a direct suture for short nerve defects. The company was founded by Rivelino Montenegro and Thomas Freier in 2006 and is headquartered in Mainz, Germany. | Medical Specialties | Director/Board Member | |
DIB Doblinger Industriebeteiligung GmbH & Co. Holding KG
DIB Doblinger Industriebeteiligung GmbH & Co. Holding KG Financial ConglomeratesFinance DIB Doblinger Industriebeteiligung GmbH & Co. Holding KG is a private equity firm. The company is based in Munich, Germany. | Financial Conglomerates | Corporate Officer/Principal | |
QIAGEN N.V. | Medical Specialties | Founder | |
EVOTEC SE | Pharmaceuticals: Major | Founder | |
U3 Pharma AG
U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | President | |
QureInvest AG
QureInvest AG Investment ManagersFinance QureInvest AG targets seed and early stage companies located in Germany and Switzerland. It seeks investments in biotechnology and life sciences firms. | Investment Managers | Founder | |
Siloanlagen Achberg Holding GmbH
Siloanlagen Achberg Holding GmbH Financial ConglomeratesFinance Siloanlagen Achberg Holding GmbH is an investment holding private company. The company is based in Achberg, Germany. The CEO of the German company is Gerd Maass. | Financial Conglomerates | Chief Executive Officer |
Statistics
International
United States | 11 |
Germany | 9 |
Switzerland | 3 |
Italy | 2 |
Netherlands | 2 |
Sectoral
Health Technology | 9 |
Finance | 6 |
Consumer Services | 5 |
Commercial Services | 4 |
Technology Services | 2 |
Operational
Founder | 11 |
Director/Board Member | 10 |
Chief Executive Officer | 4 |
President | 3 |
Corporate Officer/Principal | 2 |
Most connected contacts
Insiders | |
---|---|
Karsten Henco | 12 |
Thomas Chalberg | 11 |
Gerd Maass | 2 |
Christian Plank | 1 |
Justin Duckworth | 1 |
- Stock Market
- Insiders
- Carsten Rudolph
- Company connections